All In Biotech

Drug Trial Radar · NCT00721955

Staccato Loxapine in Agitated Patients With Bipolar Disorder

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multi-Dose Efficacy and Safety Study of Staccato® Loxapine for Inhalation in Patients With Bipolar I Disorder and Acute Agitation

Last checked: Nov 20, 2026Latest source record: Jul 26, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 314 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

314

Actual

Start

Jul 2008

Primary completion

Oct 2008

Study completion Oct 2008

Sponsor

Lead sponsor
Alexza Pharmaceuticals, Inc.Not stated
Sponsor type
Not stated
First posted
Jul 25, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 3 safety and efficacy study of Staccato Loxapine in the treatment of acute agitation in bipolar 1 disorder patients.

Conditions

  • Bipolar I Disorder

Interventions

  • Inhaled PlaceboDrug

    Inhaled loxapine Placebo, may repeat after 2 hours x 2

  • Inhaled loxapine 5 mgDrug

    Inhaled Staccato loxapine 5 mg, may repeat after 2 hours x 2

  • Inhaled loxapine 10 mgDrug

    Inhaled Staccato loxapine 10 mg, may repeat after 2 hours x 2

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in PANSS Excited Component (PEC) Score From Baseline Following Dose #1 of Staccato Loxapine, Compared With PlaceboTime frame: Baseline and 2 hours

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Synergy Escondido

    Escondido, California

  • Collaborative NeuroScience Network, Inc.

    Garden Grove, California

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • FutureSearch Trials

    Austin, Texas

  • Claghorn-Lesem Research Clinic

    Houston, Texas

  • Northwest Clinical Research Center

    Bellevue, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.